World Medical & Health Policy

Cover image for Vol. 6 Issue 4

Edited By: Arnauld Nicogossian, Otmar Kloiber, Thomas Zimmerman, Anatoly Grigoriev, and Bonnie Stabile

Online ISSN: 1948-4682

Author Guidelines

Who Can Submit?
Anyone may submit an original article to be considered for publication in World Medical & Health Policy. The author should own the initial copyright to the work being submitted, or be authorized by the copyright owner or owners, to submit the article.

Important Information for Authors
The Editors prescreen all submissions for compliance with author guidelines prior to forwarding manuscripts for peer review. Manuscripts with missing information, subjected to Internet translation, or not conforming to submission guidelines will be returned to the author(s) for corrections and resubmission.

Submitted manuscripts are generally limited to between 3,500 and 7,500 words for original articles, 1,000 and 3,000 words for commentaries, and about 800 words for book reviews.

General Submission Rules (adapted from the ICMJE:
Submissions of manuscripts and book reviews should be uploaded via the journal website by clicking on "Submit an article" under "For Contributors”. The Title Page, Acknowledgements and Author Contact Information should be submitted in a Word document separate from the manuscript to allow for blind peer review.

Research articles based on conceptual or modeling studies, and reviews, should adhere as much as possible [or applicable] to the following outline:

  1. Title Page: Concise manuscript titles are easier. Authors should include all information in the title that will make electronic retrieval of the article both sensitive and specific. The title page should reflect the content of the article.
    It should also include the authors' names and institutional affiliations: each author's highest academic degree(s), the name of the department(s) and institution(s) to which the work should be attributed.
  2. Abstract: The Abstract, not to exceed 150 words, should be a synopsis of the article and its contribution, not merely a reiteration of the first or concluding paragraph of the article.
  3. Acknowledgements: Institutional releases, recognition of prior publication or presentation, and all contributors to the publication [all contributors listed should be informed of their inclusion by the responsible or first author, and agree to their inclusion].
  4. Contact information for corresponding authors: The name, mailing address, telephone number, and e-mail address of the author responsible for correspondence about the manuscript. The corresponding author should indicate clearly whether his or her e-mail address can be published. The name and address of the author to whom requests for reprints should be addressed should be specified. Unless explicitly stated, all authors listed will be considered responsible, and guarantors, for the integrity of the research and content of the manuscript.
  5. Conflicts of Interest: Source(s) of support in the form of grants, equipment, or in-kind contributions, such as medications, and any other potential sources of conflicts of interest, should be revealed.
  6. Introduction or Background (either is acceptable): Should provide a context for the manuscript (that is, the nature of the problem addressed and its significance).
  7. Materials and Methods: This section should include only information that was available at the time the plan or protocol was approved. If applicable, intramural research or ethics research boards for the protection of human or animal test subjects' approval should be stated. This section should address:

    a. The methods used for locating, selecting, extracting, and synthesizing data, literature inclusion criteria, and scales for strength of evidence rating.
    The statistical methodology should be described with sufficient detail to enable a knowledgeable reader to verify the reported results. Statistical terms, abbreviations, and symbols should be defined. Statistical software used, if applicable, should be identified and clearly described.

    b. Selection and Description of Participants (subjects)
    Selection of the observational or experimental participants (patients or laboratory animals, including controls), including eligibility and exclusion criteria and a description of the source population, should be discussed. Because the relevance of such variables as age and sex to the object of research is not always clear, authors should explain their use when they are included in a study report-for example, authors should explain why only participants of certain ages were included or why either gender was excluded. The guiding principle should be clarity about how and why a study was done in a particular way. When authors use such variables as race or ethnicity, they should define how they measured these variables and justify their relevance.

    c. The 7th revision of the Declaration of Helsinki, World Medical Association (WMA), might be applicable if adopted by the country of the primary author's residence. WMA recommends:

    "Every research study involving human subjects must be registered in a publicly accessible database before recruitment of the first subject. Researchers, authors, sponsors, editors and publishers all have ethical obligations with regard to the publication and dissemination of the results of research. Researchers have a duty to make publicly available the results of their research on human subjects and are accountable for the completeness and accuracy of their reports. All parties should adhere to accepted guidelines for ethical reporting. Negative and inconclusive as well as positive results must be published or otherwise made publicly available. Sources of funding, institutional affiliations and conflicts of interest must be declared in the publication. Reports of research not in accordance with the principles of this Declaration should not be accepted for publication."
  8. Results: All results should be presented in a logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Extra or supplementary materials and technical detail can be placed in an appendix where they will be accessible but will not interrupt the flow of the text.
  9. Discussion: New and important aspects of the study and the conclusions that follow from them should be emphasized.
  10. Conclusions and Policy Implications: This is a medical and health policy journal. The authors are strongly encouraged to establish a relationship between their findings and policy relevant, and of interest, to national and international journal readership. Linking the conclusions with the goals of the study, while avoiding unqualified statements and conclusions not adequately supported by the data, is of importance. For example, making statements on economic benefits and costs should be avoided unless the manuscript includes the appropriate economic data and analyses; claiming priority or alluding to work that has not been completed should also be avoided. Novel hypotheses or ideas, when warranted, can be stated, but labeled clearly as such. Medical and health policies should be supported by the data presented and discussed. Any policies based on speculation or untested premises should be clearly identified or, as much as possible, avoided.
  11. Limitations and Bias: Knowledge gaps, limitations of the study and the adequacy of the study to prescribe a policy or medical practice standard should be clearly stated.
  12. References and Literature Citations: References, citations, and general style and grammar should follow the American Political Science Association standard (Revised 2001). This includes in text citations by author and date (Smith 2012) and an alphabetical list of references at the end of the manuscript, which includes full author names, not initials only. Verify references against original documents. Authors are responsible for checking that none of the references cite retracted articles except in the context of referring the retraction. For articles published in journals indexed in MEDLINE, the ICMJE considers PubMed the authoritative source for information about retractions. Authors can identify retracted articles in MEDLINE by using the following search term, where pt in square brackets stands for publication type: Retracted publication [pt] in PubMed.

Book Review Guidelines
Book reviews should be about 800 words in length and include the reviewed work's author, title, date of publication, publisher, and number of pages, cost, and ISBN as a heading. The reviewer's name and institution will appear at the conclusion of the review upon publication. If a review copy of a book is provided to the review author, the book review should be uploaded within three months of receipt of the book. Follow through is important as we are obligated to send a copy of a published review to any publisher who provides a free review copy to the journal.

It is the responsibility of the authors to ensure the accuracy of all referenced materials and graphics [including permission for reproduction of copyrighted materials] provided with the manuscript. Late requests for changes by the authors will delay publication and may ne-cessitate the publication of the manuscript in a later issue of the journal.

Please note: "publication" in a working-paper series does not constitute prior publication. In addition, by submitting material to World Medical & Health Policy, the author is stipulating that the material is not currently under review at another journal (electronic or print) and that he or she will not submit the material to another journal (electronic or print) until the completion of the editorial decision process at World Medical & Health Policy. If you have concerns about the submission terms for World Medical & Health Policy, please contact the editors.

Submitted articles cannot have been previously published, nor be forthcoming in an archival journal or book (print or electronic).

Copyright Agreement and OnlineOpen
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:

CTA Terms and Conditions

OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see

Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website at:

Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.

Author's checklist:

  1. Include degree and institutional affiliation.
  2. Include a statement of review by intramural or ethics research boards if human test subjects or animal care and use committees were used in the research (in the Materials and Methods section of the manuscript).
  3. Acknowledge all funding sources and applicable institutional releases (in the acknowledgments section of the submission process).
  4. Credit any presentation or prior publication of materials utilized in the submitted manuscript (in the acknowledgments section of the submission process).
  5. Obtain all permissions for reproducing copyrighted materials.
  6. Disclose any conflicts of interest. These include, but are not limited to:

    a) Any existing financial or personal interests with a company whose product figures prominently in the submitted manuscript.

    b) Any financial or personal interests with any company or organization sponsoring the research reported in the submitted manuscript.

    c) Financial or personal interests include: a current grant, contract or subcontract, or consulting agreement with a company; employment with the company/organization; acting as an expert witness on behalf of a company/organization; and holding stocks or shares in a company.

    d) Limiting the manuscript to a single political view without discussing alternative views and merits.
  7. Include a section on limitations and bias.